What's new

Orphan designation: octreotide hydrochloride Treatment of acromegaly, 12/06/2009 Positive

Orphan designation: octreotide hydrochloride Treatment of acromegaly, 12/06/2009 Positive

Apr 25, 2025 - 15:03
 0
Orphan designation: octreotide hydrochloride Treatment of acromegaly, 12/06/2009 Positive
Orphan designation: octreotide hydrochloride Treatment of acromegaly, 12/06/2009 Positive
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Duvyzat, givinostat, S...

Next Article

Orphan designation: Zanidatamab Treatment of biliary tract cancer, 19/07/2021 Po...

Related Posts

Human medicines European public assessment report (EPAR): Pritor, telmisartan, Date of authorisation: 11/12/1998, Revision: 31, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 23, 2025  0

Human medicines European public assessment report (EPAR): Izamby, denosumab, Status: Opinion

Human medicines European public assessment report (EPAR...

Apr 25, 2025  0

Human medicines European public assessment report (EPAR): Kisqali, ribociclib, Date of authorisation: 22/08/2017, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 24, 2025  0